Search Results - "Beketov, Evgeny E"
-
1
Bioprinting of Cartilage with Bioink Based on High-Concentration Collagen and Chondrocytes
Published in International journal of molecular sciences (21-10-2021)“…The study was aimed at the applicability of a bioink based on 4% collagen and chondrocytes for cartilage formation. Extrusion-based bioprinting was used for…”
Get full text
Journal Article -
2
Properties and Printability of the Synthesized Hydrogel Based on GelMA
Published in International journal of molecular sciences (20-01-2023)“…Gelatin methacryloyl (GelMA) has recently attracted increasing attention. Unlike other hydrogels, it allows for the adjustment of the mechanical properties…”
Get full text
Journal Article -
3
Cartilage Formation In Vivo Using High Concentration Collagen-Based Bioink with MSC and Decellularized ECM Granules
Published in International journal of molecular sciences (28-02-2022)“…The aim of this study was to verify the applicability of high-concentration collagen-based bioink with MSC (ADSC) and decellularized ECM granules for the…”
Get full text
Journal Article -
4
The study of hyaluronic acid compounds for neutron capture and photon activation therapies
Published in Open life sciences (01-10-2014)Get full text
Journal Article -
5
Development and Validation of the Cell-based Functional Method for Neutralizing Anti-adalimumab Antibodies Detection in Human Serum
Published in Razrabotka i registraciâ lekarstvennyh sredstv (Online) (01-03-2024)“…Introduction. Adalimumab, a fully humanized monoclonal antibody, is a tumor necrosis factor (TNFα) inactivator that is used against a number of autoimmune…”
Get full text
Journal Article -
6
A Double-blind Randomized Comparative Phase I Study to Assess Biosimilarity and Immunogenicity of "Trastuzumab" (LLC "Mabscale", Russia) and Herceptin® (F. Hoffmann-La Roche Ltd., Switzerland) in Healthy Volunteers
Published in Razrabotka i registraciâ lekarstvennyh sredstv (Online) (01-09-2023)“…Introduction. Trastuzumab is the first drug based on the monoclonal antibodies’ technology targeted to the neu oncogene expression product discovered in the…”
Get full text
Journal Article -
7
Development and Validation of the ELISA Method for Neutralizing Anti-trastuzumab Antibodies Detection in Human Blood Serum
Published in Razrabotka i registraciâ lekarstvennyh sredstv (Online) (29-05-2023)“…Introduction. Trastuzumab is the first known anti-HER2 agent, which revolutionized the treatment of one of the most common cancer types – breast cancer…”
Get full text
Journal Article